PFIZER CANADA ULC/PFIZER CANADA SRI
Registration:
19
of
44
(2020-05-04
to
2020-05-05)
Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Provide supply chain availability updates on Pfizer medicines, including vaccines, deemed essential for COVID-19 acute and community care
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19
|
Seeking reimbursement for Pfizer oncology medicines through the BC Cancer systemic drug therapy program under the Provincial Health Services Authority
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Seeking to conclude Product Listing Agreement discussions of Pfizer Innovative Medicine products with BC Pharmacare
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|